These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12709454)

  • 1. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Houghton JL
    JAMA; 2003 Apr 23-30; 289(16):2066; author reply 2069-70. PubMed ID: 12709454
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Yarows SA
    JAMA; 2003 Apr 23-30; 289(16):2068-9; author reply 2069-70. PubMed ID: 12709458
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Messerli FH; Weber MA
    JAMA; 2003 Apr 23-30; 289(16):2067-8; author reply 2069-70. PubMed ID: 12709457
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Chikamori T
    JAMA; 2003 Apr 23-30; 289(16):2066; author reply 2069-70. PubMed ID: 12709456
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Ong HT
    JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709460
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Palmer CR; Brown MJ; Mancia G; Ruilope LM;
    JAMA; 2003 Apr 23-30; 289(16):2066-7; author reply 2069-70. PubMed ID: 12709455
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors.
    Rifkin W
    JAMA; 2003 Apr 23-30; 289(16):2068; author reply 2069-70. PubMed ID: 12709459
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular outcomes and antihypertensive drug treatment in older women.
    Bursztyn M
    JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811971
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular outcomes and antihypertensive drug treatment in older women.
    Staessen JA; Thijs L; Wang J; Li Y
    JAMA; 2005 Apr; 293(13):1588; author reply 1588-9. PubMed ID: 15811972
    [No Abstract]   [Full Text] [Related]  

  • 11. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences between blood-pressure-lowering drugs.
    MacMahon S; Neal B
    Lancet; 2000 Jul; 356(9227):352-3. PubMed ID: 10972362
    [No Abstract]   [Full Text] [Related]  

  • 13. [The ALLHAT study: contributions, limitations and prospectives].
    Mancia G
    Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
    [No Abstract]   [Full Text] [Related]  

  • 14. Does it matter how hypertension is controlled?
    Chobanian AV
    N Engl J Med; 2008 Dec; 359(23):2485-8. PubMed ID: 19052130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypertension in the elderly].
    Ogihara T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():394-8. PubMed ID: 15171406
    [No Abstract]   [Full Text] [Related]  

  • 16. [The ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial): primary antihypertensive agents - diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors].
    Scholze J; Unger T
    Internist (Berl); 2003 Sep; 44(9):1193-5. PubMed ID: 14566471
    [No Abstract]   [Full Text] [Related]  

  • 17. Strengthening diuretics' role in hypertension.
    Manag Care; 2010 Sep; 19(9):46. PubMed ID: 20931893
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of arterial hypertension].
    Saragoça MA
    Rev Assoc Med Bras (1992); 1992; 38(3):159-68. PubMed ID: 1340367
    [No Abstract]   [Full Text] [Related]  

  • 19. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of arterial hypertension. Results of new intervention studies].
    Hausberg M; Kosch M; Rahn KH
    Internist (Berl); 2001 Dec; 42(12):1610-8. PubMed ID: 11793600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.